[Changes in physiological coagulation inhibitors in the nephrotic syndrome. Therapeutic consequences].
D020152:Antithrombin III Deficiency; D006023:Glycoproteins / Q000172:deficiency*; D006801:Humans; D009404:Nephrotic Syndrome / Q000097:blood*; D020151:Protein C Deficiency; D017293:Protein S; D013923:Thromboembolism / Q000209:etiology
D006023:Glycoproteins; D017293:Protein S
Modifications des inhibiteurs physiologiques de la coagulation au cours des syndromes néphrotiques. Conséquences thérapeutiques.